Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (9), 2990-2995
- https://doi.org/10.1016/j.bmcl.2008.03.056
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A decade of fragment-based drug design: strategic advances and lessons learnedNature Reviews Drug Discovery, 2007
- Benzimidazole Derivatives Bearing Substituted Biphenyls as Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase Inhibitors: Structure−Activity Relationship Studies and Identification of a Potent and Highly Selective Inhibitor JTK-109Journal of Medicinal Chemistry, 2006
- Fragment-Based Lead Discovery Using X-ray CrystallographyJournal of Medicinal Chemistry, 2004
- Control of Hepatitis C: A Medicinal Chemistry PerspectiveJournal of Medicinal Chemistry, 2004
- Fragment-based lead discoveryNature Reviews Drug Discovery, 2004
- Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: Tertiary amidesBioorganic & Medicinal Chemistry Letters, 2004
- Identification of N,N-Disubstituted Phenylalanines as a Novel Class of Inhibitors of Hepatitis C NS5B PolymeraseJournal of Medicinal Chemistry, 2003
- Hepatitis C therapeutics: current status and emerging strategiesNature Reviews Drug Discovery, 2002
- Is There a Difference between Leads and Drugs? A Historical PerspectiveJournal of Chemical Information and Computer Sciences, 2001
- Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virusProceedings of the National Academy of Sciences, 1999